Skip to main content

Chemours Company (CC) Insider Trading

In the last 90 days, no Chemours Company (CC) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 12, 2026Calderon Gerardo FamiliarOfficerOpen Market Purchase1,935$15.53$30,051
Aug 11, 2026Denise DignamChief Executive OfficerOpen Market Purchase3,378$14.95$50,501
Aug 7, 2026Alister CowanDirectorOpen Market Purchase13,000$15.62$203,060
Aug 7, 2026Michael Robert FoleyOfficerOpen Market Purchase1,934$15.51$29,996
Aug 7, 2026Joseph T. MartinkoOfficerOpen Market Purchase1,939$15.47$29,996
Aug 7, 2026Mary B CranstonDirectorOpen Market Purchase6,000$15.83$94,950
Aug 6, 2026Shane HostetterChief Financial OfficerOpen Market Purchase3,350$14.94$50,049

Common questions

CC insider trading FAQ

Are CC insiders buying or selling?
No CC insiders reported open-market purchases or sales in the last 90 days.
When was the last CC insider purchase?
No open-market insider purchase of Chemours Company stock was reported in the last 90 days.
Where does CC insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Chemours Company officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.